GNT Pharma and Toyota Tsusho Corporation Announce Strategic Partnership To Promote Drugs for CNS and Inflammatory Diseases in Japan

Privately held South Korean Global Neurotech Pharma Co., Ltd., (previously known as Neurotech Pharmaceuticals) is partnering with Japanese Toyota Tsusho Corporation to promote its leading drug candidates exclusively in Japan. Among GNT’s arsenal is the neuroprotective anti-inflammatory candidate AAD-2004, which was shown to modify disease in ALS animal models and may hold promise for the treatment of ALS patients.

Click here to read more.

Share this: